Entero Healthcare Solutions Limited
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Entero Healthcare Solutions Limited generated cash of -$366,120,000, which is more than the previous year. Cash used in financing activities reached the amount of $8,629,400,000 last year. Net change in cash is therefore $1,222,840,000.

Cash Flow

Entero Healthcare Solutions Limited (NSE:ENTERO.NS): Cash Flow
2020 -365.18M -2.03B 2.16B
2023 -453.15M -485.95M 727.64M
2024 -366.12M -7.05B 8.62B

ENTERO.NS Cash Flow Statement (2019 – 2023)

2023 2022 2019
Cash at beginning of period
253.62M465.08M661.43M
Operating activities
Net income
355.55M-36.88M9.43M
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
250.17M242.37M114.42M
Stock-based compensation expense
17.67M00
Deferred income tax benefit 17.67M00
Changes in operating assets and liabilities:
Accounts receivable, net
-667.19M-1.33B-570.64M
Inventories
-581.83M-193.94M-388.71M
Accounts payable
15.99M00
Cash generated by operating activities
-366.12M-453.15M-365.18M
Investing activities
Purchases Of Investments
-6.68B-225.92M0
Investments In Property Plant And Equipment
-54.16M-55.19M-449.53M
Acquisitions Net
-418.08M-245.74M-1.58B
Cash generated by investing activities
-7.05B-485.95M-2.03B
Financing activities
Common Stock Issued
10B2.62M0
Payments for dividends
000
Repurchases of common stock
000
Repayments of term debt
-987.62M884.87M0
Cash used in financing activities
8.62B727.64M2.16B
Net Change In Cash
1.22B-211.46M-229.89M
Cash at end of period
1.47B253.62M431.53M
Data sourceData sourceData source